… In 39 (17.1%) histopathologically classified gliomas, the subtype was revised after molecular
analysis. Complete resection was achieved in 35 patients (15.4%), and in 54 patients (23.7…

… The clinical utility of molecular profiling of tumor tissue to … , clinical “actionability” of somatic
variants, enrollment in mutation-targeted or other clinical trials, and outcome of molecular …

… called the Molecular Analysis for Therapy Choice (referred to as NCI-MATCH) that is
conducted through the National Clinical Trial Network and National Clinical Oncology Research …

… We aim to establish clinically relevant molecular subtypes … clinical information. We use
gene expression data to describe four molecular subtypes linked to distinct patterns of molecular …

… with significant clinical impact strongly suggests that the timely use of PCR-based assays,
followed by appropriate antiviral treatment, may have a determinant impact on clinical care …

… -based retrospective clinical and immunological survey was conducted in 73 males with a
definite diagnosis of X-linked agammaglobulinemia based on BTK sequence analysis. Forty-…

… in our clinic agreed to molecular genetic testing for germline mutations of theVHL gene and
were included in our register. Another 89 patients consulted us for molecular genetic testing. …

… patients who were referred to the phase I clinical trials program from February 2012 to October
2013 and who underwent molecular analysis, per previously described methodology. All …

… molecular … clinical impact of genotype determination includes diagnosis (family screening
and preclinical diagnosis); prediction of clinical phenotype (penetrance, gene-specific clinical …

… assigned to the different chemotherapies, but rather that molecular analysis directed
individualized chemotherapy assignment is feasible and yields promising results in outcomes. …